RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 67-77
  • Karen Hicks: FDA should not approve sex drug for women

    There's yet another pharmaceutical campaign on the offensive, hoping to convince women with sexual problems that a drug called Flibanserin will cure them. This compound is a central nervous system formula originally studied as a remedy for depression....
  • No. Dressing up marijuana as medicine doesn't cut it

    The relationship between a doctor and a patient is a sacred trust and a legal bond. One of the most common treatments that doctors provide to patients is to prescribe medications. When writing a prescription, the doctor stipulates a specific medication,...
  • Arrowhead Research seeks to reassure antsy investors

    Arrowhead Research seeks to reassure antsy investors
    Arrowhead Research Corp. is trying to succeed where major pharmaceutical company efforts have failed in finding a cure for one of the world's most tenacious diseases. The Pasadena biopharmaceutical company is developing so-called RNAi therapeutics. Such...
  • Local company develops training products for self-injection

    Local company develops training products for self-injection
    Twenty years ago Jeff Baker started a promotional product company in a spare bedroom in his home in Indianapolis. Today, that business, called Noble, has turned into a privately held multimillion-dollar niche product manufacturing company that takes...
  • Allergan sale to Actavis thwarts takeover attempt by Valeant

    Botox maker Allergan Inc., an Irvine company that started as a purveyor of eye drops and grew into one of the most respected pharmaceutical companies in the country, agreed to be acquired by Irish firm Actavis for $66 billion. The deal thwarts a...
  • Ingredion predicts $8 billion in sales by 2019

     Ingredion predicts $8 billion in sales by 2019
    Ingredion said Tuesday its annual sales should hit $8 billion by 2019, up from $6.33 billion last year, as the ingredients-maker pushes to notch more sales from fast-growing specialty products and international markets. The announcement comes weeks after...
  • The Medicine Cabinet-Ask the Harvard Experts: With even some generics rising in price, explore ways to cut your drug costs

    Q: Recently, my doctor prescribed a 10-day course of doxycycline. I always ask for a generic since I need to pay full price. I was shocked when the pharmacist said it would be almost $65. I took this medication three years ago and I think it cost me...
  • Generic drug prices skyrocket in past year

     Generic drug prices skyrocket in past year
    After calling for a routine prescription refill, Craig Elliott got a rude shock: His bill was going up fivefold. The 44-year-old piano tuner and guitar instructor from Elgin, who has health insurance, used to pay $20 for a three-month supply of his...
  • Though cheered by Wall Street, most mergers don't work out for buyers

    — Wall Street's big business — helping companies buy other companies — is hotter than it's been in years. When pharmaceuticals giant Actavis said it was buying Allergan Inc. in Irvine and Halliburton said it would take over rival oil-...
  • Feds to publicize drug company payments to doctors

    Feds to publicize drug company payments to doctors
    For decades, Big Pharma and medical technology firms have made gifts and other payments to physicians as part of developing, testing and marketing their products, an expense long recognized as another cost of doing business. On Tuesday, the federal...
  • Baxter seeks OK to sell new hemophilia drug

    Baxter International on Monday said it had submitted an application to the Food and Drug Administration for the approval of a key hemophilia drug. The drug, BAX 855, is an extended-release version of its flagship hemophilia drug Advate, which is sold...